N.E.W. Advisory Services’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$33.8K Hold
374
﹤0.01% 445
2026
Q1
$29.9K Hold
374
﹤0.01% 444
2025
Q4
$31.9K Buy
374
+315
+534% +$25.9K ﹤0.01% 423
2025
Q3
$4.59K Hold
59
﹤0.01% 672
2025
Q2
$4.61K Sell
59
-630
-91% -$47K ﹤0.01% 663
2025
Q1
$49.9K Buy
+689
New +$49.3K ﹤0.01% 359

Other funds holding EW

N.E.W. Advisory Services's EW Position: Q2 2026 in Review

N.E.W. Advisory Services held its Edwards Lifesciences (EW) position steady in Q2 2026 at 374 shares worth $33.8K. The position accounts for ﹤0.01% of the portfolio, ranked #445.

N.E.W. Advisory Services first reported a position in EW in Q1 2025 and has held it in 6 quarters since. The position peaked at $49.9K in Q1 2025. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • N.E.W. Advisory Services held 374 shares of Edwards Lifesciences worth $33.8K as of Q2 2026.
  • N.E.W. Advisory Services left its Edwards Lifesciences share count unchanged in Q2 2026.
  • Edwards Lifesciences made up ﹤0.01% of N.E.W. Advisory Services's portfolio in Q2 2026, its #445 holding.
  • N.E.W. Advisory Services first reported a position in Edwards Lifesciences in Q1 2025 and has held it in 6 quarters since.
  • N.E.W. Advisory Services's Edwards Lifesciences position peaked at $49.9K in Q1 2025.
  • 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on N.E.W. Advisory Services's 13F filing for Q2 2026, filed 6 Aug 2026.